-
1
-
-
0028604318
-
Clinical aspects of miltefosine and its topical formulation
-
Hilgard P, Engel J. Clinical aspects of miltefosine and its topical formulation. Drugs of today 1994;30(Suppl. B):13-20.
-
(1994)
Drugs of Today
, vol.30
, Issue.SUPPL. B
, pp. 13-20
-
-
Hilgard, P.1
Engel, J.2
-
2
-
-
0037191710
-
Oral miltefosine for Indian visceral leishmaniasis
-
Sundar S, Jha TK, Thakur CP, Engel J, Sindermamm H, Fischer C et al. Oral miltefosine for Indian visceral leishmaniasis. N Engl J Med 2002;347: 1739-46.
-
(2002)
N Engl J Med
, vol.347
, pp. 1739-1746
-
-
Sundar, S.1
Jha, T.K.2
Thakur, C.P.3
Engel, J.4
Sindermamm, H.5
Fischer, C.6
-
3
-
-
0035503414
-
Randomized, double-blind, placebo-controlled, multicenter trial of 6p. 100 miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer
-
Leonard R, Hardy J, van Tienhoven G, Houston S, Simmonds P, David M et al. Randomized, double-blind, placebo-controlled, multicenter trial of 6p. 100 miltefosine solution, a topical chemotherapy in cutaneous metastases from breast cancer. J Clin Oncol 2001;19:4150-9.
-
(2001)
J Clin Oncol
, vol.19
, pp. 4150-4159
-
-
Leonard, R.1
Hardy, J.2
Van Tienhoven, G.3
Houston, S.4
Simmonds, P.5
David, M.6
-
4
-
-
0031047459
-
Miltefosine in recurrent cutaneous breast cancer
-
Clive S, Leonard RCF. Miltefosine in recurrent cutaneous breast cancer. Lancet 1997;349:621-2.
-
(1997)
Lancet
, vol.349
, pp. 621-622
-
-
Clive, S.1
Leonard, R.C.F.2
-
5
-
-
0027486720
-
Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: Results of phase I/II study
-
Dummer R, Krasovec M, Röger J, Sindermann H, Burg G. Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: results of phase I/II study. J Am Acad Dermatol 1993;29:963-70.
-
(1993)
J Am Acad Dermatol
, vol.29
, pp. 963-970
-
-
Dummer, R.1
Krasovec, M.2
Röger, J.3
Sindermann, H.4
Burg, G.5
-
6
-
-
0026620987
-
Topical application of hexadecylphosphocholine in patients with cutaneous lymphomas
-
Dummer R, Röger J, Vogt T, Becker J, Hefner H, Sindermann H et al. Topical application of hexadecylphosphocholine in patients with cutaneous lymphomas. Prog Exp Tumor Res 1992;34:160-9.
-
(1992)
Prog Exp Tumor Res
, vol.34
, pp. 160-169
-
-
Dummer, R.1
Röger, J.2
Vogt, T.3
Becker, J.4
Hefner, H.5
Sindermann, H.6
-
7
-
-
18744409589
-
Phase II study of 6p. 100 miltefosine solution as a local treatment in cutaneous metastatic melanoma
-
Khayat D, Bonerandi JJ, Delaunay MM, Avril MF, David M. Phase II study of 6p. 100 miltefosine solution as a local treatment in cutaneous metastatic melanoma. Proc Am Soc Clin Oncol 1996;15:1339.
-
(1996)
Proc Am Soc Clin Oncol
, vol.15
, pp. 1339
-
-
Khayat, D.1
Bonerandi, J.J.2
Delaunay, M.M.3
Avril, M.F.4
David, M.5
-
8
-
-
0031350650
-
Antiproliferation effects of hexadecylphosphocholine on solid tumour and leukemia selectively in vitro
-
Wang YZ, Liu Xy, Wu LJ, Zhang YB, Hou L, Xu QS. Antiproliferation effects of hexadecylphosphocholine on solid tumour and leukemia selectively in vitro. Drugs Exp Clin Res 1997;23:97-102.
-
(1997)
Drugs Exp Clin Res
, vol.23
, pp. 97-102
-
-
Wang, Y.Z.1
Liu, Xy.2
Wu, L.J.3
Zhang, Y.B.4
Hou, L.5
Xu, Q.S.6
|